Chitosan Nanoparticles, a Novel Drug Delivery System to Transfer Squalene for Hepatocyte Stress Protection

The Mediterranean diet is a well-known dietary pattern that has gained considerable popularity worldwide for its ability to prevent the progression of nonalcoholic fatty liver disease. This is largely attributed to the use of virgin olive oil as the primary source of fat, which contains a substantial amount of squalene, a natural antioxidant. In order to enhance the delivery of squalene and amplify its effects due to its highly hydrophobic nature, herein, squalene has been incorporated into chitosan nanoparticles. The characterization of the resulting nanoparticles was conducted via scanning electron microscopy, dynamic light scattering, ζ potential, Fourier transform infrared spectroscopy, and gas chromatography-mass spectrometry. Reactive oxygen species (ROS) generation and cell viability assays were conducted in oxidative and endoplasmic reticulum (ER) stress in AML12 and a TXNDC5-deficient AML12 cell line, which was generated by CRISPR/Cas9 technology. The results demonstrated that squalene was successfully encapsulated in chitosan nanoparticles and exhibited rapid and efficient cellular uptake at a 150 μM squalene concentration within 48 h. In conclusion, the encapsulation of squalene in chitosan nanoparticles, compared to the poly(d,l-lactide-<i>co</i>-glycolic acid) and ethanol drug carriers, significantly enhanced its cellular uptake. This allows the administration of higher doses, which improve hepatocyte viability and reduce ROS levels, effectively compensating for the adverse effects of TXNDC5 deficiency under the context of hepatocyte stress protection.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2024-12-16
DOI
https://doi.org/10.1021/acsomega.4c08258
Citations
6
Primary Topic
Lipid Membrane Structure and Behavior
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chitosan Nanoparticles, a Novel Drug Delivery System to Transfer Squalene for Hepatocyte Stress Protection

María Á. Navarro, Jesús Osada, Arnaud Petitpas, Susana C. M. Fernandes et al.
6 citations
ACS Omega
Lipid Membrane Structure and Behavior
1.40
article

Chitosan Nanoparticles, a Novel Drug Delivery System to Transfer Squalene for Hepatocyte Stress Protection

María Á. Navarro, Jesús Osada, Arnaud Petitpas, Susana C. M. Fernandes, Seyed Hesamoddin Bidooki, Léa Spitzer, María Jesús Rodriguez‐Yoldi, Javier Sánchez-Marco, Roberto Martínez‐Beamonte, Virginie Pellerin, Roberto Lasheras
article en
6 citations

Abstract

The Mediterranean diet is a well-known dietary pattern that has gained considerable popularity worldwide for its ability to prevent the progression of nonalcoholic fatty liver disease. This is largely attributed to the use of virgin olive oil as the primary source of fat, which contains a substantial amount of squalene, a natural antioxidant. In order to enhance the delivery of squalene and amplify its effects due to its highly hydrophobic nature, herein, squalene has been incorporated into chitosan nanoparticles. The characterization of the resulting nanoparticles was conducted via scanning electron microscopy, dynamic light scattering, ζ potential, Fourier transform infrared spectroscopy, and gas chromatography-mass spectrometry. Reactive oxygen species (ROS) generation and cell viability assays were conducted in oxidative and endoplasmic reticulum (ER) stress in AML12 and a TXNDC5-deficient AML12 cell line, which was generated by CRISPR/Cas9 technology. The results demonstrated that squalene was successfully encapsulated in chitosan nanoparticles and exhibited rapid and efficient cellular uptake at a 150 μM squalene concentration within 48 h. In conclusion, the encapsulation of squalene in chitosan nanoparticles, compared to the poly(d,l-lactide-<i>co</i>-glycolic acid) and ethanol drug carriers, significantly enhanced its cellular uptake. This allows the administration of higher doses, which improve hepatocyte viability and reduce ROS levels, effectively compensating for the adverse effects of TXNDC5 deficiency under the context of hepatocyte stress protection.

ACS OmegaVol. 9(52)
Centre National de la Recherche Scientifique (FR), Université de Pau et des Pays de l'Adour (FR), Universidad de Zaragoza (ES), Instituto de Salud Carlos III (ES), Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (ES), Institut des Sciences Analytiques et de Physico-Chimie pour l'Environnement et les Matériaux (FR), Centro de Investigación y Tecnología Agroalimentaria de Aragón (ES), Institut des Sciences Analytiques (FR), Instituto de Investigación Sanitaria Aragón (ES), Gobierno de Aragón (ES)
Ministerio de Ciencia, Innovación y Universidades, Agence Nationale de la Recherche, Centre National de la Recherche Scientifique, Universidad de Zaragoza, Gobierno de Aragón, Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición, Fundación Bancaria Ibercaja, Université de Pau et des Pays de l'Adour, Instituto de Salud Carlos III, European Regional Development Fund, Division of Materials Research, European Social Fund
Good health and well-being
Openalex Percentile: Top 18%
Lipid Membrane Structure and Behavior
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.